C11 ER176 PET in Evaluating Neuroinflammation in Patients With Post-COVID Syndrome
Mayo Clinic
Summary
The purpose of this research is to find out if Positron Emission Tomography (PET) imaging with an investigational drug called C-11 ER176 can help us learn more about Post-COVID Syndrome.
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * Mayo Clinic patients with a previously confirmed infection with the novel SARS-CoV-2 virus who have been seen in the Post COVID Clinic through GIM Integrative Medicine \& Health Section or approval by MAGPIES research group. * Be able to participate fully in all aspects of the study. * Have understood and signed study informed consent. Exclusion Criteria: * Lacking the capacity to consent. * Prisoners and institutionalized individuals. * Reports being currently pregnant, lactating, or are of child-bearing potential or are likely to become pregnant during the LLLT treat…
Interventions
- DrugC11 ER176 Tracer
C11 ER176 tracer will be administered by IV, followed by PET imaging of the brain to evaluate for neuroinflammation
Location
- Mayo ClinicRochester, Minnesota